Search Results - "Haug, J. B."

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? by Lerang, F, Moum, B, Haug, J B, Tolås, P, Breder, O, Aubert, E, Høie, O, Søberg, T, Flaaten, B, Farup, P, Berge, T

“…To compare cure rates of Helicobacter pylori (H. pylori) infection, ulcer healing, and side effects of three simplified regimens of triple therapy in patients…”
Get more information

Bloodstream Infections at a Norwegian University Hospital, 1974–1979 and 1988–1989: Changing Etiology, Clinical Features, and Outcome by Haug, J. B., Harthug, S., Kalager, T., Digranes, A., Solberg, C. O.

“…All episodes of bloodstream infection in patients admitted to a Norwegian university hospital in 1974–1979 and in 1988–1989 were analyzed; altogether, there…”
Get full text

Accuracy of IgG Serology and Other Tests in Confirming Helicobacter pylori Eradication by LERANG, F, HAUG, J. B, MOUM, B, MOWINCKEL, P, BERGE, T, RAGNHILDSTVEIT, E, BJØRNEKLETT, A

“…Background: In this study we assessed the accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Methods: The outcome of…”
Get full text

Accuracy of Seven Different Tests for the Diagnosis of Helicobacter pylori Infection and the Impact of H2-Receptor Antagonists on Test Results by Lerang, F, Moum, B, Mowinckel, P, Haug, J B, Ragnhildstveit, E, Berge, T, Bjørneklett, A

“…Background: In this study we compared the accuracy of seven diagnostic tests in diagnosing Helicobacter pylori infection. Methods: Over 1 year 351 consecutive…”
Get full text

Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection : Experience from clinical practice in a population with a high frequency of metronidazole resistance by LERANG, F, MOUM, B, RAGNHILDSTVEIT, E, SANDVEI, P. K, TOLAS, P, WHIST, J. E, HENRIKSEN, M, HAUG, J. B, BERGE, T

“…To evaluate the cure rate of Helicobacter pylori infection, including the impact of in vitro metronidazole resistance (M-R), and the side effects of a…”
Get full text

A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study by Lerang, F, Moum, B, Ragnhildstveit, E, Haug, J B, Hauge, T, Tolås, P, Aubert, E, Henriksen, M, Efskind, P S, Nicolaysen, K, Søberg, T, Odegaard, A, Berge, T

“…To compare the efficacy and side effects of standard bismuth triple therapy with those of omeprazole-based triple therapy in patients with Helicobacter pylori…”
Get more information

Highly Effective Second-Line Anti-Helicobacter pylori Therapy in Patients with Previously Failed Metronidazole-Based Therapy by Lerang, F., Moum, B., Haug, J. B., Berge, T., Tolas, P., Sandvei, P. K., Torp, R., Tønnesen, T.

“…Background: In this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously…”
Get full text

WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance by Haug, Jon Birger, Reikvam, Åsmund

“…To investigate effects on surveillance results of hospital antibiotic use when WHO defined daily doses (WHO DDDs) are adjusted to doses recommended for…”
Get full text

Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009 by ZARB, Peter, AMADEO, Brice, MULLER, Arno, DRAPIER, Nico, VANKERCKHOVEN, Vanessa, DAVEY, Peter, GOOSSENS, Herman

“…Since electronic prescribing is limited to few hospitals, point prevalence surveys, such as the standardized European Surveillance of Antimicrobial Consumption…”
Get full text

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response by Dalgard, Olav, Bjøro, Kristian, Ring‐Larsen, Helmer, Bjornsson, Einar, Holberg‐Petersen, Mona, Skovlund, Eva, Reichard, Olle, Myrvang, Bjørn, Sundelöf, Bo, Ritland, Ståle, Hellum, Kjell, Frydén, Aril, Florholmen, Jon, Verbaan, Hans

“…A recent nonrandomized pilot trial showed that hepatitis C virus (HCV) patients with genotype 2/3 and rapid virological response (RVR) had a 90% sustained…”
Get full text

Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate by Haug, Jon Birger, Berild, Dag, Walberg, Mette, Reikvam, Åsmund

“…Objectives Although antibiotic use and resistance are low in Norway, the situation risks changing for the worse. We investigated trends in antibiotic use and…”
Get full text

Dangerous bacterial conditions by Haug, J B

Get full text

Simplified 10-Day Bismuth Triple Therapy for Cure ofHelicobacter pyloriInfection: Experience From Clinical Practice in a Population With a High Frequency of Metronidazole Resistance by Lerang, F, Mourn, B, Ragnhildstveit, E, Sandvei, P K, Tolås, P, Whist, J E, Henriksen, M, Haug, J B, Berge, T

Get full text

Infectious endocarditis by Haug, J B

Get more information

Accuracy of Seven Different Tests for the Diagnosis of Helicobacter pylori Infection and the Impact of H 2 -Receptor Antagonists on Test Results by F. LERANG, B. MOUM, P. MOWINCKEL, J

Get full text

Bloodstream infectious at a norwegian university hospital, 1974-1979 anf 1988-1989 : changing etiology, clinical features, and outcome by HAUG, J. B, HARTUNG, S, KALAGER, T, DIGRANES, A, SOLBERG, C. O

Get full text